Brodsky & Smith LLC has announced investigations into whether the boards of Lumentum Holdings, ARRAY Technologies, Surgery Partners, and Range Resources breached their fiduciary duties during recent merger agreements. These probes focus on whether the companies conducted fair processes and offered fair value to shareholders amid significant ownership changes post-merger. Investors owning shares in these companies are encouraged to contact Brodsky & Smith for more information. These investigations could impact shareholder rights and merger outcomes.
Range Resources Corporation has a market cap of $11.42 billion and a dividend yield of 0.82%, while Lumentum Holdings holds a market cap of $54.06 billion as of Nov 10, 2026 22:42 WIB. On Pluang, Lumentum trades at USD 593.00 with a 1-day change of -0.53%, and Range Resources is up 1.98% at USD 49.85. These figures provide current market context for the companies involved in the investigations announced by Brodsky & Smith.
Marvell Technology's stock valuation has halved recently, but it remains a 'Strong Buy' due to its faster growth and strong business momentum. The company's $115 billion all-stock acquisition of Lumentum adds significant optics capabilities, $1 billi...
Marvell Technology and Western Digital both experienced their worst weekly stock declines since 2001, dropping about 28% despite raising their earnings guidance. The selloff was largely driven by election results and concerns over AI data center poli...
Marvell Technology has been upgraded to a Buy rating with a new fair value of $187.35 standalone and $199.48 including its acquisition of Lumentum. The upgrade follows improved fiscal guidance for 2028 and 2031, along with a significant contract win ...
Coherent's stock surged 13% after it reported better-than-expected Q1 FY2027 revenue and earnings, and announced a $20 billion long-term AI optics deal starting in 2028. Despite a recent 43% drop, the company remains the last independent laser maker ...
Marvell Technology's stock dropped over 50% in one month following its all-stock acquisition of Lumentum, causing significant dilution concerns among investors. Despite the steep decline, analysts remain optimistic, with an average price target sugge...
